Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.

Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page
- Check2 days agoChange DetectedThe page footer revision was updated from v3.6.3 to v3.6.4, signaling a minor site maintenance update. This change does not modify the study content or how information is presented.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.6.3 now appears in the page footer, indicating a recent update to the page version. The previous revision tag, Revision: v3.6.0, has been removed.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page adds sections for How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment header, while removing the previous Intervention / Treatment label. It also updates the recruitment status to 'No longer looking for participants' and changes the footer revision to v3.6.0.SummaryDifference0.5%

- Check58 days agoChange DetectedRevision: v3.5.5 was added and previously v3.5.4 was removed, indicating a new site build/version. This change updates the site metadata without altering the study details.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page revision history shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating a small metadata update to the entry. This does not reflect substantive changes to study details or content.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page’s software/display footer revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.